Bile Cell Block‐Derived DNA for Next‐Generation Sequencing in Cholangiocarcinoma: A Comparison With Surgical Specimens
Journal of Hepato-Biliary-Pancreatic Sciences · 06.11.2026
DOI: 10.1002/jhbp.70209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 06.11.2026. Verfasst von Mitsuru Okuno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, The Japanese Foundation for Research and Promotion of Endoscopy, Japan Association for the Advancement of Medical Equipment.
Abstract (Originalsprache)
Objectives
A sufficient amount of cancer tissue for next‐generation sequencing (NGS) is difficult to obtain from patients with unresectable cholangiocarcinoma. We evaluated whether bile cell block (CB) samples provide a DNA source of sufficient quantity and quality for NGS compared with surgical specimens.
Methods
NGS results of paired bile CB and surgical specimens from 14 patients were compared.
Results
Median number of malignant cells on one glass slide of CB specimen was 50. Although median DNA concentration and amount of extracted DNA were significantly lower in the CB than those in the surgical specimens, NGS success rate did not differ significantly (CB, 64%; surgical specimen, 86%). In a pair‐wise comparison of eight patients with successful NGS of both bile CB and surgical specimens, median gene matching rate was 99%, and median coverage rate of surgical genes based on CB genes was 100%. The presence of ≥ 30 malignant cells on a single slide was identified as a practical indicator of successful NGS of CB using receiver operating characteristic curve, and this threshold increased the NGS success rate to 80%.
Conclusions
As bile CB is easy to prepare in general hospitals, bile cell‐based NGS may help address the difficulty of obtaining surgical NGS samples for cholangiocarcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.
- Department of Gastroenterology, Matsunami General Hospital, Gifu, Japan.
- Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
- Department of Diagnostic Pathology, Gifu Municipal Hospital, Gifu, Japan.
- Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan.
- First Department of Internal Medicine, Gifu University Hospital, Gifu, Japan.
ORCID-Profile: Mitsuru Okuno, Tomohiro Kanayama, Keisuke Iwata, Takuji Tanaka, Yohei Shirakami, Tsuyoshi Mukai, Hisataka Moriwaki
Förderung
- JSPS KAKENHI
- The Japanese Foundation for Research and Promotion of Endoscopy
- Japan Association for the Advancement of Medical Equipment
- Japanese Foundation for Research and Promotion of Endoscopy
Zitieren
APA
Okuno, M., Kanayama, T., Iwata, K., Tanaka, T., Tomita, H., Shirakami, Y., Watanabe, N., Mukai, T., Moriwaki, H., & Shimizu, M. (2026). Bile Cell Block‐Derived DNA for Next‐Generation Sequencing in Cholangiocarcinoma: A Comparison With Surgical Specimens. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70209
Vancouver
Okuno M, Kanayama T, Iwata K, Tanaka T, Tomita H, Shirakami Y, et al. Bile Cell Block‐Derived DNA for Next‐Generation Sequencing in Cholangiocarcinoma: A Comparison With Surgical Specimens. Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70209
BibTeX
@article{Okuno2026,
author = {Okuno, Mitsuru and Kanayama, Tomohiro and Iwata, Keisuke and Tanaka, Takuji and Tomita, Hiroyuki and Shirakami, Yohei and Watanabe, Naoki and Mukai, Tsuyoshi and Moriwaki, Hisataka and Shimizu, Masahito},
title = {Bile Cell Block‐Derived DNA for Next‐Generation Sequencing in Cholangiocarcinoma: A Comparison With Surgical Specimens},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
doi = {10.1002/jhbp.70209}
}
EUVIMED